摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2’-氧代异环磷酰胺 | 119670-13-2

中文名称
2’-氧代异环磷酰胺
中文别名
——
英文名称
3-chloroacetyltetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
英文别名
3-(2-Chloroactyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide;2-chloro-1-[2-(2-chloroethylamino)-2-oxo-1,3,2λ5-oxazaphosphinan-3-yl]ethanone
2’-氧代异环磷酰胺化学式
CAS
119670-13-2
化学式
C7H13Cl2N2O3P
mdl
——
分子量
275.072
InChiKey
KJRISYCCYWZCOF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    355.0±52.0 °C(Predicted)
  • 密度:
    1.42±0.1 g/cm3(Predicted)
  • 溶解度:
    可溶于氯仿(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    58.6
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:9a0029a0cd612485512865f22844576e
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Ifosfamide, analogues thereof and their preparation
    申请人:——
    公开号:US20020052521A1
    公开(公告)日:2002-05-02
    The present invention pertains to a compound of formula (I) 1 wherein R 1 and R 2 are each (CH 2 ) m X, each X is Cl or Br and m is 2 or 3, in combination with less than 0.5% w/w of the corresponding compound wherein R 1 is (CH 2 ) m H. Such compounds can be prepared by (i) the reaction of a Bronsted acid or a Lewis acid with NaBH 4 in an organic solvent, and (ii) adding the resultant solution to a solution of a corresponding compound wherein one of R 1 and R 2 is CO(CH 2 ) n X and the other is CO(CH 2 ) n X or (CH 2 ) m X, wherein n=m−1. Such compounds can also be prepared, in optically-enriched form, starting from an optically-enriched trihaloiminophosphorane of the formula R*N=Phal 3 wherein NR* is a chiral moiety derivable from a chiral amine or chiral sulphonamide of the formula R*NH 2 , which can be cyclisable with HO(CH 2 ) 3 NHR.
    本发明涉及一种式(I)的化合物,其中R1和R2均为(CH2)mX,每个X为Cl或Br,m为2或3,与相应化合物中R1为( )mH的化合物相比,其含量小于0.5% w/w。这些化合物可以通过以下步骤制备:(i)用有机溶剂反应Bronsted酸或Lewis酸与NaBH4;(ii)将所得溶液加入其中一个R1和R2分别为CO( )nX和CO( )nX或( )mX的相应化合物的溶液中,其中n=m-1。这些化合物也可以以光学纯形式制备,其起始物为式R*N=Phal3的光学纯三卤代亚酰胺,其中NR*是可由手性胺或手性磺酰胺的式R*NH2衍生的手性基团,可与HO( )3NHR环化。
  • Misiura, Konrad, Pharmazie, 2004, vol. 59, # 9, p. 668 - 672
    作者:Misiura, Konrad
    DOI:——
    日期:——
  • Process for the production of the derivatives of 1,3,2-oxazaphosphorinane
    申请人:INSTYTUT PRZEMYSLU FARMACEUTYCZNEGO
    公开号:EP0295576B1
    公开(公告)日:1993-05-19
  • STEC, WOJCIECH J.;RADZIKOWSKI, CZEALAW;SZELEJEWSKI, WIESLAW;KINAS, RYSSAR+
    作者:STEC, WOJCIECH J.、RADZIKOWSKI, CZEALAW、SZELEJEWSKI, WIESLAW、KINAS, RYSSAR+
    DOI:——
    日期:——
  • STEC, WOJCIECH J.;RADZIKOWSKI, CZESLAW;SZELEJEWSKI, WIESLAW;KINAS, RYSZAR+
    作者:STEC, WOJCIECH J.、RADZIKOWSKI, CZESLAW、SZELEJEWSKI, WIESLAW、KINAS, RYSZAR+
    DOI:——
    日期:——
查看更多

同类化合物

曲磷胺 曲磷胺 异环磷酰胺杂质F 异环磷酰胺 [(2-羟基-2-氧代-1,4,2-氧氮杂磷杂环己烷-4-基)甲基]膦酸 4-过氧化氢异环磷酰胺 4-氧代异环磷酰胺 4-乙基-7-甲基-7-氮杂-2,6-二氧杂-1-磷杂双环[2.2.2]辛烷1-硫化物 2’-氧代异环磷酰胺 2-[2-氯乙基-[3-(2-氯乙基)-2-氧代-1-氧杂-3-氮杂-2-磷杂环己-2-基]氨基]乙基甲烷磺酸酯 2,3,4,6,7,8-六氢-[1,3,2]氧氮杂膦咛并[2,3-b][1,3,2]氧氮杂膦咛 (2-氯-乙基)-[(R)-3-(2-氯-乙基)-2-氧代-2lambda5-[1,3,2]氧氮杂磷杂环己烷-2-基]-胺 (S)-2-Chloro-4-isobutyl-[1,3,2]oxazaphospholidine 2-sulfide (SCRP)-2-anilino-3-(α-methylbenzyl)-1,3,2λ5-oxazaphosphorinane 2-oxide 2-Chlor-1-(β-chlorethylamino)-1,3,2-azaoxaphosphorinan (SCSP)-2-anilino-3-(α-methylbenzyl)-1,3,2λ5-oxazaphosphorinane 2-oxide 2-[4-(2-Piperidin-1-yl-ethyl)-piperazin-1-yl]-[1,3,2]oxazaphosphinane 2-oxide (5-tert-Butyl-3-phenyl-[1,3,2]oxazaphosphinan-2-yl)-dimethyl-amine 4-Hydroperoxyisophosphamid-6-14C (E)-3-tert-butyl-6,6-dimethyl-2-oxo-[2'-((E)-2-butenyloxy)-1'-butenyl]-1,3,2-oxazaphosphorinane trichloroethyl cyclophosphoramidate 2(S)--3-<(R)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 3-sec-Butyl-2-(2-chloro-ethylsulfanyl)-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-propylsulfanyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-propylsulfanyl)-[1,3,2]oxazaphosphinane 2-oxide 2(S)--3-<(S)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 3-sec-Butyl-2-(2-chloro-ethylsulfanyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-1-methyl-propoxy)-[1,3,2]oxazaphosphinane 2-sulfide 2-hexadecyloxy-3-methyl-[1,3,2]oxazaphosphinane 2-oxide cis-4-Hydroperoxytrofosfamide 2(S)--3-<(R)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 2H-1,3,2-Oxazaphosphorin-2-amine,N,N-diethyltetrahydro-3-(phenylmethyl)- 3-sec-Butyl-2-(2-chloro-1-methyl-ethoxy)-[1,3,2]oxazaphosphinane 2-sulfide cis-2-methoxy-2-thio-5-tert-butyl-1,3,2-oxazaphosphorinane 3,7,10-trimethyl-1-phenylgermatrane 2-{(2-Chloro-ethyl)-[3-(2-chloro-ethyl)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl]-amino}-ethanol 3-benzyl-2-chloro-[1,3,2]oxazaphosphinane 2-(O,O-Di-n-propyl-phosphordithiomethylen)-2-methyl-1,3-oxazolidin cis-2,3-diphenyl-2-oxo-5-tert-butyl-1,3,2λ5-oxazaphosphorinane 2-ethoxy-[1,3,2]oxazaphosphinane 2-oxide 1-Acetyl-2-diaethylamino-1,3,2-azaoxaphosphorinan 1,5-dioxa-2,6-dioxo-2,4,4,6,8,8-hexakis(pyrrolidino)cyclotetraphosphadiazadiene (2,4-dimethyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-3-yl)-phosphonous acid bis-diethylamide 2,6,6,9,12,12-hexamethyl-3,10-diphenyl-1,8-dioxa-4,11-dithia-2,9-diaza-dispiro[4.1.4.1]dodecane 2-isopropoxy-[1,3,2]oxazaphosphinane 2-sulfide 2-thioxo-2λ5-[1,3,2]oxazaphosphinan-2-ylamine (2R,3S,5S)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane 2-propoxy-[1,3,2]oxazaphosphinane 2-(diethylthiocarbamoylthio)-3-phenyl-1,3,2-oxazaphospholidine